Strikingly, there is a growing body of evidence from mouse studies and melanoma patient data that increased Biglycan levels promotes melanoma metastasis [87], drives tumour angiogenesis [88, 89] and correlate with poor patient outcomes [87, 89]. Here, BGN is linked to melanoma.